Etobicoke, Canada

Michael Glenn Loveless

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Inmedix, Inc.. Active years: 2024-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Glenn Loveless: Innovator in Portable Electrocardiogram Technology

Introduction

Michael Glenn Loveless is a notable inventor based in Etobicoke, Canada. He has made significant contributions to the field of medical technology, particularly with his innovative designs that enhance patient care. His work focuses on creating devices that are both functional and user-friendly.

Latest Patents

Michael holds a patent for a portable electrocardiogram device with a touchscreen display. This invention represents a significant advancement in the monitoring of heart health, allowing for easier access and usability for both patients and healthcare providers. The device is designed to provide accurate readings while being compact and portable.

Career Highlights

Michael is currently employed at Inmedix, Inc., where he continues to develop cutting-edge medical technologies. His role at the company allows him to collaborate with other talented professionals in the field, driving innovation forward.

Collaborations

Throughout his career, Michael has worked alongside notable colleagues such as Andrew J. Holman and Steven Ross Daly. These collaborations have fostered an environment of creativity and innovation, leading to the development of impactful medical devices.

Conclusion

Michael Glenn Loveless is a dedicated inventor whose work in portable electrocardiogram technology is making a difference in healthcare. His contributions are paving the way for more accessible and efficient medical monitoring solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…